Key statistics dashboard for Apimeds Pharmaceuticals US, Inc (APUS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Stock Data
| Price | $1.60 |
| Market Cap | $2M |
| Beta | -1.37 |
| Exchange | AMEX |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.03 |
| Price / Book | 0.03 |
| P/S | 0.00 |
| P/FCF | -0.18 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Current Ratio | 0.51 |
| Quick Ratio | 0.51 |
| Cash Ratio | 0.01 |
| Debt / Equity | 0.14 |
| Debt / Assets | 11.42% |
| Interest Coverage | -4.47 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 65.19 |
| Cash per share | 0.17 |
| FCF per share | -8.52 |
| Tangible Book Value per share | 65.19 |
| Dividend per share | 0.00 |
Related companies: ANTX · IGC · MIRA · MLSS · MYO · NXTC · POCI
Explore sector: Healthcare · Biotechnology
More sections of APUS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks